Literature DB >> 24762082

Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis.

Mineaki Goto1, Hiroshi Miwa, Masato Shikami, Norikazu Tsunekawa-Imai, Kazuto Suganuma, Shohei Mizuno, Miyuki Takahashi, Motonori Mizutani, Ichiro Hanamura, Masakazu Nitta.   

Abstract

Some cancer cells depend on glutamine despite of pronounced glycolysis. We examined the glutamine metabolism in leukemia cells, and found that HL-60 cells most depended on glutamine in the 4 acute myelogenous leukemia (AML) cell lines examined: growth of HL-60 cells was most suppressed by glutamine deprivation and by inhibition of glutaminolysis, which was rescued by tricarboxylic acid (TCA) cycle intermediate, oxaloacetic acid. Glutamine is also involved in antioxidant defense function by increasing glutathione. Glutamine deprivation suppressed the glutathione content and elevated reactive oxygen species most evidently in HL-60 cells. Glutamine metabolism might be a therapeutic target in some leukemia.

Entities:  

Keywords:  AML; Anaplerosis; Glutamine; Glutathione; TCA cycle

Mesh:

Substances:

Year:  2014        PMID: 24762082     DOI: 10.3109/07357907.2014.907419

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  31 in total

1.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

2.  Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.

Authors:  Mark A Gregory; Travis Nemkov; Julie A Reisz; Vadym Zaberezhnyy; Kirk C Hansen; Angelo D'Alessandro; James DeGregori
Journal:  Exp Hematol       Date:  2017-09-22       Impact factor: 3.084

Review 3.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

4.  High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.

Authors:  L Poulain; P Sujobert; F Zylbersztejn; S Barreau; L Stuani; M Lambert; T L Palama; V Chesnais; R Birsen; F Vergez; T Farge; C Chenevier-Gobeaux; M Fraisse; F Bouillaud; C Debeissat; O Herault; C Récher; C Lacombe; M Fontenay; P Mayeux; T T Maciel; J-C Portais; J-E Sarry; J Tamburini; D Bouscary; N Chapuis
Journal:  Leukemia       Date:  2017-03-10       Impact factor: 11.528

Review 5.  Cell intrinsic and extrinsic regulation of leukemia cell metabolism.

Authors:  Yajian Jiang; Daisuke Nakada
Journal:  Int J Hematol       Date:  2016-02-20       Impact factor: 2.490

6.  Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML.

Authors:  Megan E Zavorka Thomas; Xiyuan Lu; Zahra Talebi; Jae Yoon Jeon; Daelynn R Buelow; Alice A Gibson; Muhammad Erfan Uddin; Lindsey T Brinton; Julie Nguyen; Meghan Collins; Alessia Lodi; Shannon R Sweeney; Moray J Campbell; Douglas H Sweet; Alex Sparreboom; Rosa Lapalombella; Stefano Tiziani; Sharyn D Baker
Journal:  Mol Cancer Ther       Date:  2021-09-13       Impact factor: 6.261

Review 7.  The Metabolic Profiles in Hematological Malignancies.

Authors:  Tao Liu; Xing-Chun Peng; Bin Li
Journal:  Indian J Hematol Blood Transfus       Date:  2019-04-23       Impact factor: 0.900

8.  Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma.

Authors:  Nicole M Anderson; Xiaodan Qin; Jennifer M Finan; Andrew Lam; Jacob Athoe; Rindert Missiaen; Nicolas Skuli; Annie Kennedy; Amandeep S Saini; Ting Tao; Shizhen Zhu; Itzhak Nissim; A Thomas Look; Guoliang Qing; M Celeste Simon; Hui Feng
Journal:  Cancer Res       Date:  2021-07-07       Impact factor: 12.701

9.  Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias.

Authors:  Daniel L Sun; Soumya Poddar; Roy D Pan; Ethan W Rosser; Evan R Abt; Juno Van Valkenburgh; Thuc M Le; Vincent Lok; Selena P Hernandez; Janet Song; Joanna Li; Aneta Turlik; Xiaohong Chen; Chi-An Cheng; Wei Chen; Christine E Mona; Andreea D Stuparu; Laurent Vergnes; Karen Reue; Robert Damoiseaux; Jeffrey I Zink; Johannes Czernin; Timothy R Donahue; Kendall N Houk; Michael E Jung; Caius G Radu
Journal:  RSC Med Chem       Date:  2020-02-24

10.  Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML.

Authors:  Bradley Stockard; Neha Bhise; Miyoung Shin; Joy Guingab-Cagmat; Timothy J Garrett; Stanley Pounds; Jatinder K Lamba
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.